Dr. Halsey's presentation at the National
Vaccine Advisory Committee Workshop on Thimerosal and Vaccines
held in Bethesda, Maryland on August 11-12, 1999.
Slide 16 of 26
We need to tell physicians and parents about the
options available for reducing mercury exposures. If only a
single thimerosal-containing vaccine is administered such as
Hib or DTaP at two, four and six months of age, then only
the very smallest infants receive more than the total
monthly mercury exposure allowed under the ATSDR guidelines.